Multiple Sclerosis - Diffusion Tensor MRI Correlates of Depression
Protocol ID
03.02.084T
Protocol Description
The purpose of this study is to see whether subtle changes in specific pathways of the brain may lead to depression in people with multiple sclerosis.
We will be using a noninvasive technique called diffusion tensor MRI to generate pictures of the brain. We will be comparing four different groups of people: patients with multiple sclerosis and depression, patients with multiple sclerosis without depression, patients with depression without multiple sclerosis, and people without multiple sclerosis or depression.
This study does not involve any treatment.
Eligibility Criteria
Patients with multiple sclerosis with or without depression, patients with depression without multiple sclerosis, and normal healthy controls.
Primary Investigator(s)
- Marc L. Gordon, MD
Contact Information
Last Update
April 5, 2010How did I get to this page?
Related Information
- News Room
-
Clinical Trials
- Movement Disorders - Functional Correlates Study (08-191)
- Drug Use, Depression and Anxiety - Qi Gong Study (06-081)
- Bipolar Disorder - ECT Follow-up Study (04.08.132T)
- Brain and Behavior in Dystonia: A Multicenter Study (03.02.079G)
- Parkinson's Disease - Molecular Basis for Cognitive Impairment (06-108T)
- Laparoscopic Experience and Functional Brain Activation (07-106)
- Schizophrenia - Functional MRI of Medication Effects (02.04.030)
- Systemic Lupus Erythematosus - PET/MRI Study (07-012)
- Bipolar Disorder - Clinical Trial (08-001)
- Epilepsy - Cognitive and Sensorimotor Study (07-125)
- Depression - COMED Study (07.04.133)
- REM Behavior Disorder and Parkinsonism: Longitudinal PET Study (08-126)
- Opiod Analgesic Depression - Clinical Trial (06.04.109T)
- Parkinson’s Disease - Early Differential Diagnosis of Parkinsonism with Metabolic Imaging and Pattern Analysis
- Schizophrenia - Genetic Study (08-252)
- Brain and Behavior in Dystonia Study (08-283)
- Huntington's Disease - Clinical Trial (09-012)
- Prolonging Remission in Depressed Elderly (PRIDE) (09-078)
- Parkinson’s Disease - Microvascular Changes in Parkinson’s Disease: Relationship to Levodopa-Induced Dyskinesia
- Parkinson’s Disease - Metabolic Networks and the Cognitive Treatment Response in Parkinson’s Disease
General Navigation
Persistent Navigation
-
Clinical Trials
- Addiction
- Aging
- Allergies
- Arthritis
- Autoimmune Disease
- Blood Disorders
- Cancer
- Children's Health
- Circulation
- Dental
- Diabetes
- Ear & Hearing
- Eyes
- Gastrointestinal/Hepatitis
- Genetics
- Heart
- HIV
- Infectious Diseases
- Joints
- Kidney
- Lung
- Lupus
- Men's Health
-
Mental Health
- Alzheimer's Disease - Endocannabinoid System Study (05.04.140)
- Alzheimer's Disease - Memantine Study (06.02.108T)
- Autism Spectrum Disorders - Adult Study (07.04.051)
- Bipolar Disorder
- Clinical Correlates of Memory Impairment (03.08.160)
- Cognitive Aging: Screening and Genetic Associations (07-127)
- Cognitive Enhancement in Bipolar Disorder (05-069)
- Dementia - Clinical Trial (08-295)
- Depression
- Ecopipam Treatment of Tourette's Disorder (PSY301, 10-02-226-03)
- Genetic Correlates of Memory Impairment (03.04.169T)
- Genetics and Dimensions of Psychopathology (09-062)
- Genetics of Early Onset Psychiatric Disorders (06-097)
- Genetics of Psychiatric Disorders (04.04.077)
- Healthy Volunteers - Screening for Research Studies (05.04.022T)
- Induced Pluripotent Stem Cells (IPS) and Psychiatric Disorders (09-280)
- Memory Disorders Study (08-219)
- Multiple Sclerosis - Diffusion Tensor MRI Correlates of Depression (03.02.084T)
- Obsessive Compulsive Disorder
- Pitch Recognition in Autistic Spectrum Disorders (04-053)
- Psychosis - Early Detection/Prevention Study (07.04.075)
- Psychosis - PET Study (09-037)
- Schizophrenia
- Tourette Syndrome - Genetic Study (08-003)
- Neurosciences
- Recruitment Registry
- Skin
- Sleep Disorders
- Smoking
- Urinary Tract
- Weight Control
- Women's Health